0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Krabbe Disease Treatment Market by Therapy Type, Administration Route, Treatment Setting, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030 - Product Thumbnail Image

Krabbe Disease Treatment Market by Therapy Type, Administration Route, Treatment Setting, Distribution Channel, End User, Patient Age Group - Global Forecast to 2030

  • Report
  • May 2025
  • 187 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions - Product Thumbnail Image

Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions

  • Report
  • September 2024
  • 375 Pages
  • Global
From
EUR$4,799USDGBP
Transdermal CNS Therapeutics to 2028 - Product Thumbnail Image

Transdermal CNS Therapeutics to 2028

  • Report
  • July 2023
  • 115 Pages
  • Global
From
EUR$3,850USDGBP
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • October 2023
  • 68 Pages
  • Global
From
EUR$9,995USDGBP
Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030 - Product Thumbnail Image

Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030

  • Report
  • September 2021
  • 150 Pages
  • Global
From
EUR$4,799USDGBP
ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 407 Pages
  • Global
From
EUR$4,799USDGBP
IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • March 2024
  • 221 Pages
  • Global
From
EUR$2,450USDGBP
Rheumatoid Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 150 Pages
  • Global
From
EUR$5,850USDGBP
Systemic Lupus Erythematosus (Sle) Drugs - Global Strategic Business Report - Product Thumbnail Image

Systemic Lupus Erythematosus (Sle) Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 184 Pages
  • Global
From
EUR$5,850USDGBP
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 182 Pages
  • Global
From
EUR$5,850USDGBP
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 181 Pages
  • Global
From
EUR$5,850USDGBP
Psoriatic Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 276 Pages
  • Global
From
EUR$5,850USDGBP
Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • July 2024
  • 120 Pages
  • Global
From
EUR$5,950USDGBP
Psoriasis Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Type; By Route Of Administration; and By Region - Product Thumbnail Image

Psoriasis Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Type; By Route Of Administration; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
EUR$3,150USDGBP
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 127 Pages
  • Global
From
EUR$14,995USDGBP
Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • October 2022
  • 270 Pages
  • Global
From
EUR$3,750USDGBP
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 696 Pages
  • Global
From
EUR$2,500USDGBP
Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2027 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2027

  • Report
  • July 2023
  • 200 Pages
  • Global
From
EUR$4,500USDGBP
Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027

  • Report
  • July 2023
  • 218 Pages
  • Global
From
EUR$4,500USDGBP
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
EUR$3,000USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more